NCT04992234View on ClinicalTrials.gov

COVID-19 Antibody Responses in Cystic Fibrosis

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Cystic FibrosisCovid19
Trial Locations (2)

Unknown

Sahlgrenska University Hospital, Gothenburg

Karolinska University Hospital, Huddinge

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

collaborator

Queen's University, Belfast

OTHER

collaborator

European Cystic Fibrosis Society - Clinical Trials Network

OTHER

collaborator

Cystic Fibrosis Foundation

OTHER

lead

Vastra Gotaland Region

OTHER_GOV